Home / CSPCY : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CSPCY make money? Does CSPCY have pricing power? What's the Earnings Whisper? Will CSPCY profit more as the business scales? What is CSPCY's management track record? Is CSPCY's current price justified?

CSPC Pharmaceutical Group Limited

$4.39 +$0.06 (+1.39%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$4.36

Day Range

$4.39$4.4

Year Range

$3.26$5.63

Market Cap

12.65B

AVG Volume

2.06K

Trailing/Forward PE

11.57/-

PEG ratio

-0.39

Dividend Yield

3.29%

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CNY)

CSPCY Revenue (CNY) by quarter
Period	Revenue (CNY)
26 Q2	18.39B
25 Q4	12.49B
25 Q2	1.67B
24 Q4	13.7B
24 Q2	16.28B
23 Q4	7.78B
23 Q2	8.03B
22 Q4	15.23B
22 Q2	16.09B
21 Q4	13.87B

Net Income (CNY)

CSPCY Net Income (CNY) by quarter
Period	Net Income (CNY)
26 Q2	6.03B
25 Q4	1.31B
25 Q2	320.68M
24 Q4	1.33B
24 Q2	3.02B
23 Q4	1.53B
23 Q2	1.54B
22 Q4	1.5B
22 Q2	1.56B
21 Q4	2.51B

Operating Income (CNY)

CSPCY Operating Income (CNY) by quarter
Period	Operating Income (CNY)
26 Q2	7.27B
25 Q4	1.38B
25 Q2	2.58B
24 Q4	1.57B
24 Q2	3.7B
23 Q4	1.79B
23 Q2	1.7B
22 Q4	4.99B
22 Q2	3.58B
21 Q4	3.09B

EBITDA (CNY)

CSPCY EBITDA (CNY) by quarter
Period	EBITDA (CNY)
26 Q2	7.92B
25 Q4	2.08B
25 Q2	3.18B
24 Q4	2.35B
24 Q2	4.52B
23 Q4	1.79B
23 Q2	1.91B
22 Q4	2.55B
22 Q2	2.46B
21 Q4	3.52B

Cash Flows (CNY)

CSPCY Cash Flows (CNY) by quarter
Period	Cash Flows (CNY)
26 Q2	0
25 Q4	1.99B
25 Q2	264.79M
24 Q4	1.76B
24 Q2	775.86M
23 Q4	2.1B
23 Q2	437.76M
22 Q4	1.71B
22 Q2	3.79B
21 Q4	913.26M

EPS (CNY)

CSPCY EPS (CNY) by quarter
Period	EPS (CNY)
26 Q2	2.12
25 Q4	0.48
25 Q2	0.11
24 Q4	0.44
24 Q2	1.08
23 Q4	0.96
23 Q2	0.52
22 Q4	1.04
22 Q2	1
21 Q4	0.84

Expenses (CNY)

CSPCY Expenses (CNY) by quarter
Period	Expenses (CNY)
26 Q2	6.74B
25 Q4	7.58B
25 Q2	6.29B
24 Q4	8.65B
24 Q2	8.6B
23 Q4	7.32B
23 Q2	8.79B
22 Q4	5.39B
22 Q2	8.98B
21 Q4	8.47B

Cash & Debt (CNY)

CSPCY Cash & Debt (CNY) by quarter
Period	Cash & Debt (CNY)
26 Q2	18.49B
25 Q4	8.87B
25 Q2	9.7B
24 Q4	8.25B
24 Q2	10.81B
23 Q4	13.05B
23 Q2	12.09B
22 Q4	15.18B
22 Q2	13.41B
21 Q4	10.71B

Debt ratios

CSPCY Debt ratios by quarter
Period	Debt ratios
26 Q2	-1.15
25 Q4	-0.68
25 Q2	-0.78
24 Q4	-0.73
24 Q2	-0.97
23 Q4	-1.42
23 Q2	-1.12
22 Q4	-1.21
22 Q2	-0.94
21 Q4	-0.76

Margins

CSPCY Margins by quarter
Period	Margins
26 Q2	76.15%
25 Q4	65.57%
25 Q2	521.66%
24 Q4	68.19%
24 Q2	71.57%
23 Q4	239.94%
23 Q2	71.25%
22 Q4	69.41%
22 Q2	70.45%
21 Q4	75.55%

Return on Capital

CSPCY Return on Capital by quarter
Period	Return on Capital
26 Q2	15.28%
25 Q4	3.79%
25 Q2	0.92%
24 Q4	3.93%
24 Q2	8.28%
23 Q4	4.38%
23 Q2	4.59%
22 Q4	4.78%
22 Q2	5.31%
21 Q4	9.38%

Shares Outstanding

CSPCY Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	2.85B
25 Q4	2.88B
25 Q2	2.86B
24 Q4	2.93B
24 Q2	2.96B
23 Q4	2.96B
23 Q2	2.98B
22 Q4	2.98B
22 Q2	2.98B
21 Q4	2.99B

Dividends (CNY)

CSPCY Dividends (CNY) by quarter
Period	Dividends (CNY)
Oct 26	0.09
Jun 26	0.08
Oct 25	0.07
Jun 25	0.05
Nov 24	0.08
Jun 24	0.07
Sep 23	0.07
Jun 23	0.06
Sep 22	0.05
May 22	0.05

Book Value Per Share (CNY)

CSPCY Book Value Per Share (CNY) by quarter
Period	Book Value Per Share (CNY)
26 Q2	13.84
25 Q4	12
25 Q2	12.2
24 Q4	11.54
24 Q2	12.32
23 Q4	11.78
23 Q2	11.26
22 Q4	10.54
22 Q2	9.88
21 Q4	8.96

Total Assets (CNY)

CSPCY Total Assets (CNY) by quarter
Period	Total Assets (CNY)
26 Q2	56.04B
25 Q4	46.71B
25 Q2	46B
24 Q4	44.39B
24 Q2	47.87B
23 Q4	46.15B
23 Q2	43.67B
22 Q4	41.51B
22 Q2	38.85B
21 Q4	34.68B

PE Ratio

CSPCY PE Ratio by quarter
Period	PE Ratio
Sep 26	14.19
Sep 26	16.49
Aug 26	15.82
Aug 26	14.87
Aug 26	14.39
Aug 26	14.31
Jul 26	14.02
Jul 26	14.07
Jul 26	13.36
Jul 26	13.62
Jul 26	12.56
Jun 26	11.11
Jun 26	11.25
Jun 26	11.8
Jun 26	12.32
May 26	12.23
May 26	12.87
May 26	13.06
May 26	13.63
May 26	14.15
Apr 26	14.96
Apr 26	15.11
Apr 26	15.37
Apr 26	16.92
Mar 26	14.85
Mar 26	14.32
Mar 26	13.61
Mar 26	15.14
Feb 26	15.72
Feb 26	16.41
Feb 26	16.5
Feb 26	15.91
Jan 26	15.48
Jan 26	15.99
Jan 26	15.91
Jan 26	15.03
Jan 26	13.97
Dec 25	14.51
Dec 25	13.67
Dec 25	12.56
Dec 25	12.65
Nov 25	13.12
Nov 25	12.42
Nov 25	13.23
Nov 25	12.32
Oct 25	12.87
Oct 25	13.37
Oct 25	15.35
Oct 25	15.99
Oct 25	16.29
Sep 25	13.21
Sep 25	14.53
Sep 25	15.11
Sep 25	16.12
Aug 25	14.82
Aug 25	15.09
Aug 25	15.41
Aug 25	14.61
Aug 25	14.21
Jul 25	12.34
Jul 25	13.24
Jul 25	11.21
Jul 25	11.69
Jun 25	11.18
Jun 25	10.88
Jun 25	12.9
Jun 25	12.69
May 25	11.54
May 25	9.89
May 25	8.36
May 25	8.31
May 25	9.04
Apr 25	9.03
Apr 25	8.09
Apr 25	7.5
Apr 25	7.61
Mar 25	7.34
Mar 25	6.82
Mar 25	6.86
Mar 25	6.83
Feb 25	6.9
Feb 25	7.16
Feb 25	6.82
Feb 25	6.43
Jan 25	6.22
Jan 25	6.19
Jan 25	6.43
Jan 25	6.24
Jan 25	6.6
Dec 24	6.83
Dec 24	6.89
Dec 24	6.84
Dec 24	7.15
Nov 24	7.12
Nov 24	7.24
Nov 24	7.36
Nov 24	7.37
Nov 24	7.33
Oct 24	8.72
Oct 24	9.17

Free Cash Flow Yield

CSPCY Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	5.65%
Sep 26	4.86%
Aug 26	5.07%
Aug 26	5.39%
Aug 26	5.57%
Aug 26	5.6%
Jul 26	5.71%
Jul 26	5.7%
Jul 26	6%
Jul 26	5.88%
Jul 26	6.38%
Jun 26	7.21%
Jun 26	7.12%
Jun 26	6.79%
Jun 26	6.5%
May 26	6.55%
May 26	6.23%
May 26	6.13%
May 26	5.88%
May 26	5.66%
Apr 26	5.36%
Apr 26	5.3%
Apr 26	5.21%
Apr 26	4.73%
Mar 26	5.32%
Mar 26	5.52%
Mar 26	5.81%
Mar 26	5.22%
Feb 26	5.03%
Feb 26	4.82%
Feb 26	4.79%
Feb 26	4.97%
Jan 26	5.11%
Jan 26	4.94%
Jan 26	4.97%
Jan 26	5.26%
Jan 26	5.66%
Dec 25	5.45%
Dec 25	5.78%
Dec 25	6.29%
Dec 25	6.25%
Nov 25	6.03%
Nov 25	6.36%
Nov 25	5.98%
Nov 25	6.42%
Oct 25	6.14%
Oct 25	5.91%
Oct 25	5.15%
Oct 25	4.94%
Oct 25	4.85%
Sep 25	5.18%
Sep 25	4.71%
Sep 25	4.53%
Sep 25	4.24%
Aug 25	4.62%
Aug 25	4.53%
Aug 25	4.44%
Aug 25	4.68%
Aug 25	4.81%
Jul 25	5.54%
Jul 25	5.17%
Jul 25	6.1%
Jul 25	5.85%
Jun 25	6.12%
Jun 25	6.29%
Jun 25	5.3%
Jun 25	5.39%
May 25	5.93%
May 25	6.92%
May 25	8.18%
May 25	8.24%
May 25	7.57%
Apr 25	7.58%
Apr 25	8.46%
Apr 25	9.12%
Apr 25	8.99%
Mar 25	9.03%
Mar 25	9.72%
Mar 25	9.65%
Mar 25	9.7%
Feb 25	9.59%
Feb 25	9.26%
Feb 25	9.71%
Feb 25	10.31%
Jan 25	10.64%
Jan 25	10.7%
Jan 25	10.3%
Jan 25	10.62%
Jan 25	10.04%
Dec 24	9.69%
Dec 24	9.62%
Dec 24	9.68%
Dec 24	9.27%
Nov 24	9.3%
Nov 24	9.15%
Nov 24	9%
Nov 24	8.99%
Nov 24	9.03%
Oct 24	7.6%
Oct 24	7.22%

Price to Sales

CSPCY Price to Sales by quarter
Period	Price to Sales
Sep 26	1.92
Sep 26	2.23
Aug 26	2.14
Aug 26	2.01
Aug 26	1.95
Aug 26	1.94
Jul 26	1.9
Jul 26	1.9
Jul 26	1.81
Jul 26	1.84
Jul 26	1.7
Jun 26	1.5
Jun 26	1.52
Jun 26	1.6
Jun 26	1.67
May 26	1.66
May 26	1.74
May 26	1.77
May 26	1.85
May 26	1.92
Apr 26	2.03
Apr 26	2.05
Apr 26	2.08
Apr 26	2.29
Mar 26	2.33
Mar 26	2.25
Mar 26	2.14
Mar 26	2.38
Feb 26	2.47
Feb 26	2.58
Feb 26	2.59
Feb 26	2.5
Jan 26	2.43
Jan 26	2.51
Jan 26	2.5
Jan 26	2.36
Jan 26	2.19
Dec 25	2.28
Dec 25	2.15
Dec 25	1.97
Dec 25	1.99
Nov 25	2.06
Nov 25	1.95
Nov 25	2.08
Nov 25	1.94
Oct 25	2.02
Oct 25	2.1
Oct 25	2.41
Oct 25	2.51
Oct 25	2.56
Sep 25	2.14
Sep 25	2.35
Sep 25	2.45
Sep 25	2.61
Aug 25	2.4
Aug 25	2.44
Aug 25	2.49
Aug 25	2.37
Aug 25	2.3
Jul 25	2
Jul 25	2.14
Jul 25	1.81
Jul 25	1.89
Jun 25	1.81
Jun 25	1.76
Jun 25	2.09
Jun 25	2.05
May 25	1.87
May 25	1.6
May 25	1.35
May 25	1.34
May 25	1.46
Apr 25	1.46
Apr 25	1.31
Apr 25	1.21
Apr 25	1.23
Mar 25	1.18
Mar 25	1.09
Mar 25	1.1
Mar 25	1.09
Feb 25	1.11
Feb 25	1.15
Feb 25	1.09
Feb 25	1.03
Jan 25	1
Jan 25	0.99
Jan 25	1.03
Jan 25	1
Jan 25	1.06
Dec 24	1.1
Dec 24	1.1
Dec 24	1.1
Dec 24	1.15
Nov 24	1.14
Nov 24	1.16
Nov 24	1.18
Nov 24	1.18
Nov 24	1.18
Oct 24	1.4
Oct 24	1.47

EV/EBITDA

CSPCY EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	6.32
Sep 26	7.45
Aug 26	7.12
Aug 26	6.65
Aug 26	6.41
Aug 26	6.37
Jul 26	6.23
Jul 26	6.25
Jul 26	5.9
Jul 26	6.03
Jul 26	5.51
Jun 26	4.8
Jun 26	4.87
Jun 26	5.14
Jun 26	5.4
May 26	5.35
May 26	5.66
May 26	5.76
May 26	6.04
May 26	6.29
Apr 26	6.69
Apr 26	6.77
Apr 26	6.89
Apr 26	7.66
Mar 26	7
Mar 26	6.72
Mar 26	6.35
Mar 26	7.15
Feb 26	7.45
Feb 26	7.81
Feb 26	7.86
Feb 26	7.55
Jan 26	7.33
Jan 26	7.59
Jan 26	7.55
Jan 26	7.09
Jan 26	6.53
Dec 25	6.82
Dec 25	6.38
Dec 25	5.8
Dec 25	5.85
Nov 25	6.09
Nov 25	5.72
Nov 25	6.15
Nov 25	5.67
Oct 25	5.96
Oct 25	6.22
Oct 25	7.26
Oct 25	7.59
Oct 25	7.75
Sep 25	8.54
Sep 25	9.46
Sep 25	9.87
Sep 25	10.58
Aug 25	9.66
Aug 25	9.85
Aug 25	10.08
Aug 25	9.52
Aug 25	9.24
Jul 25	7.93
Jul 25	8.56
Jul 25	7.13
Jul 25	7.47
Jun 25	7.11
Jun 25	6.9
Jun 25	8.32
Jun 25	8.17
May 25	7.36
May 25	6.21
May 25	5.13
May 25	5.1
May 25	5.61
Apr 25	5.6
Apr 25	4.94
Apr 25	4.53
Apr 25	4.61
Mar 25	4.2
Mar 25	3.83
Mar 25	3.86
Mar 25	3.84
Feb 25	3.89
Feb 25	4.07
Feb 25	3.84
Feb 25	3.56
Jan 25	3.42
Jan 25	3.39
Jan 25	3.56
Jan 25	3.42
Jan 25	3.68
Dec 24	3.84
Dec 24	3.88
Dec 24	3.85
Dec 24	4.07
Nov 24	4.05
Nov 24	4.13
Nov 24	4.22
Nov 24	4.22
Nov 24	4.2
Oct 24	5.18
Oct 24	5.49

Price/Operating Cashflow

CSPCY Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	10.56
Sep 26	12.27
Aug 26	11.77
Aug 26	11.06
Aug 26	10.71
Aug 26	10.64
Jul 26	10.43
Jul 26	10.46
Jul 26	9.94
Jul 26	10.13
Jul 26	9.35
Jun 26	8.26
Jun 26	8.37
Jun 26	8.78
Jun 26	9.17
May 26	9.1
May 26	9.57
May 26	9.72
May 26	10.14
May 26	10.53
Apr 26	11.13
Apr 26	11.24
Apr 26	11.43
Apr 26	12.59
Mar 26	11.27
Mar 26	10.87
Mar 26	10.33
Mar 26	11.49
Feb 26	11.93
Feb 26	12.45
Feb 26	12.52
Feb 26	12.07
Jan 26	11.75
Jan 26	12.13
Jan 26	12.07
Jan 26	11.4
Jan 26	10.59
Dec 25	11.01
Dec 25	10.37
Dec 25	9.53
Dec 25	9.6
Nov 25	9.95
Nov 25	9.42
Nov 25	10.03
Nov 25	9.34
Oct 25	9.76
Oct 25	10.14
Oct 25	11.64
Oct 25	12.13
Oct 25	12.35
Sep 25	10.58
Sep 25	11.63
Sep 25	12.1
Sep 25	12.91
Aug 25	11.86
Aug 25	12.08
Aug 25	12.33
Aug 25	11.7
Aug 25	11.38
Jul 25	9.88
Jul 25	10.6
Jul 25	8.97
Jul 25	9.36
Jun 25	8.95
Jun 25	8.71
Jun 25	10.33
Jun 25	10.16
May 25	9.24
May 25	7.92
May 25	6.69
May 25	6.65
May 25	7.24
Apr 25	7.23
Apr 25	6.48
Apr 25	6.01
Apr 25	6.09
Mar 25	6.17
Mar 25	5.73
Mar 25	5.76
Mar 25	5.74
Feb 25	5.8
Feb 25	6.01
Feb 25	5.73
Feb 25	5.4
Jan 25	5.23
Jan 25	5.2
Jan 25	5.4
Jan 25	5.24
Jan 25	5.54
Dec 24	5.74
Dec 24	5.79
Dec 24	5.75
Dec 24	6
Nov 24	5.98
Nov 24	6.08
Nov 24	6.19
Nov 24	6.19
Nov 24	6.16
Oct 24	7.33
Oct 24	7.7

Price to Book

CSPCY Price to Book by quarter
Period	Price to Book
Sep 26	2.45
Sep 26	2.85
Aug 26	2.74
Aug 26	2.57
Aug 26	2.49
Aug 26	2.47
Jul 26	2.43
Jul 26	2.43
Jul 26	2.31
Jul 26	2.36
Jul 26	2.17
Jun 26	1.92
Jun 26	1.95
Jun 26	2.04
Jun 26	2.13
May 26	2.12
May 26	2.23
May 26	2.26
May 26	2.36
May 26	2.45
Apr 26	2.59
Apr 26	2.61
Apr 26	2.66
Apr 26	2.93
Mar 26	2.64
Mar 26	2.55
Mar 26	2.42
Mar 26	2.69
Feb 26	2.79
Feb 26	2.92
Feb 26	2.93
Feb 26	2.83
Jan 26	2.75
Jan 26	2.84
Jan 26	2.83
Jan 26	2.67
Jan 26	2.48
Dec 25	2.58
Dec 25	2.43
Dec 25	2.23
Dec 25	2.25
Nov 25	2.33
Nov 25	2.21
Nov 25	2.35
Nov 25	2.19
Oct 25	2.29
Oct 25	2.38
Oct 25	2.73
Oct 25	2.84
Oct 25	2.89
Sep 25	2.89
Sep 25	3.18
Sep 25	3.31
Sep 25	3.53
Aug 25	3.24
Aug 25	3.3
Aug 25	3.37
Aug 25	3.2
Aug 25	3.11
Jul 25	2.7
Jul 25	2.9
Jul 25	2.45
Jul 25	2.56
Jun 25	2.45
Jun 25	2.38
Jun 25	2.82
Jun 25	2.78
May 25	2.53
May 25	2.16
May 25	1.83
May 25	1.82
May 25	1.98
Apr 25	1.98
Apr 25	1.77
Apr 25	1.64
Apr 25	1.67
Mar 25	1.53
Mar 25	1.42
Mar 25	1.43
Mar 25	1.42
Feb 25	1.44
Feb 25	1.49
Feb 25	1.42
Feb 25	1.34
Jan 25	1.3
Jan 25	1.29
Jan 25	1.34
Jan 25	1.3
Jan 25	1.37
Dec 24	1.42
Dec 24	1.43
Dec 24	1.42
Dec 24	1.49
Nov 24	1.48
Nov 24	1.51
Nov 24	1.53
Nov 24	1.53
Nov 24	1.53
Oct 24	1.82
Oct 24	1.91

No video analysis for this stock yet. Request one from our team.

News: CSPCY

reuters.com · 2 Jul 2026

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

AstraZeneca has entered into a deal worth up to $1.77 billion with CSPC ‌Pharmaceutical Group to discover and develop experimental medicines with the potential to treat kidney diseases, the Chinese drugmaker said on Thursday.

AI Analysis

CSPC Pharmaceutical Group Limited

Video analysis: CSPCY

News: CSPCY

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

Similar companies